Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 344

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 344
---
LS Board self -evaluationprocess. 186 W ith regard to committee membership:(a) recommend directors for appointment to each committee (in line with the requirements of Swiss law and rules promulgated by Nasdaq or the SEC), (b) ensure members of the Audit Committee meet financial literacy and independence requirements under the rule promulgated by Nasdaq, the SEC, or other governing body, and (c) implement and monitor annual self -evaluationprocesses for committees. With regard to corporate governance oversight:(a) review and recommend changes to governance documents (articles of association, organizational rules, etc.), (b) oversee and verify annual performance evaluations of the NLS Board and committees, (c) evaluate its own performance annually and (d) keep the NLS Board informed of actions other than routine or administrative actions. With regard to adjustments to articles of association:propose changes related to remuneration and governance matters for NLS Board approval, to be ultimately approved by shareholders. With regard to the Compensation Committee Charter:review the Charter annually and recommend any changes to the NLS Board. The charter is subject to review and modification from time to time by the NLS Board as it may deem appropriate and in the best interests of the Company and its shareholders. The Compensation Committee reports regularly to the NLS Board on decisions, proposals, and non -routineitems within its remit. 187

EXECUTIVE COMPENSATION AND SHARE OWNERSHIP Kadimastem’s Employment Agreements and Indemnification Agreements Kadimastem has entered into employment agreements with each of its executive officers, which set forth the terms and conditions of each executive’s employment, including base salary, performance -basedvariable pay compensation and benefit plan participation. Under these agreements, each of its executive officers is employed for a specified time period. Kadimastem and/or its subsidiaries may terminate employment without notice, at any time, for certain acts of the executive officer, such as serious, repeated or continuing breach of internal policies or guidelines on conduct, any act or conduct which would bring the officer or Kadimastem into disrepute, any serious misconduct, unreasonable absenteeism or willful disobedience of Kadimastem lawful orders, willful refusal to perform all or any duties, insubordination, breach of Kadimastem secrecy, or violation of the laws and regulations of Israel. Kadimastem and/or its subsidiaries may also terminate an executive officer’s employment with advanced written notice. The length of such notice period is set out